Inozyme Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inozyme Pharma Inc
TickerINZY
CIK #0001693011
CUSIP45790W108
SectorLife Sciences - Pharmaceutical Preparations
Address321 Summer Street Suite 400, Boston, MA 02210
Source [EDGAR]
CIK Filing 2011 - 2024
[0001693011] 10-K
[0001693011] 10-Q
[0001693011] 3
[0001693011] 4
[0001693011] 8-K
[0001693011] D
[0001693011] SC 13D
[0001693011] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Millennium Management LLC Inozyme Pharma Inc [2023-05-31] 5.2
Sphera Funds Management Ltd Inozyme Pharma Inc [2023-03-07] 5.19
Baker Bros Advisors LP Inozyme Pharma Inc [2023-02-14] 5.1
CHI Advisors LLC Inozyme Pharma Inc [2023-02-13] 5.46
Venrock Healthcare Capital Partners II LP Inozyme Pharma Inc [2022-04-29] 0.8
Pivotal Bioventure Partners Fund I LP Inozyme Pharma Inc [2022-04-28] 6.6
Rock Springs Capital Management LP Inozyme Pharma Inc [2022-04-25] 6.12
Deep Track Capital LP Inozyme Pharma Inc [2022-04-18] 8.11
Adage Capital Partners GP LLC Inozyme Pharma Inc [2021-05-10] 5.49
Sofinnova Venture Partners X LP Inozyme Pharma Inc [2021-03-04] 11.0
RA Capital Management LP Inozyme Pharma Inc [2021-02-16] 8.6
New Enterprise Associates 15 LP Inozyme Pharma Inc [2021-02-12] 10.4
Pivotal Bioventure Partners Fund I LP Inozyme Pharma Inc [2021-02-09] 6.8
Longitude Capital Partners III LLC Inozyme Pharma Inc [2020-08-07] 11.0
Flynn James E Inozyme Pharma Inc [2020-08-06] 5.15
Pivotal Bioventure Partners Fund I LP Inozyme Pharma Inc [2020-08-04] 7.1
Novo Holdings A/S Inozyme Pharma Inc [2020-07-29] 11.5
Form 3/4/5 Filer 2011 - 2024
Hopfner Robert Lorne
Inozyme Pharma, Inc.
Bolte Axel
Winton Matthew
Subramanian Sanjay
Treco Douglas A
Bjarke Henric Bjorn
Diaz Reinaldo M
Bhagat Sarah M
Mathers Edward T
Sullivan Lynne Marie
Edwards Martin
Tammenoms Bakker Juliet
Longitude Venture Partners III, L.P.
Longitude Capital Partners III, LLC
Enright Patrick G
Pivotal bioVenture Partners Fund I, L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
Pivotal bioVenture Partners Fund I G.P., L.P.
DiPalma Stephen J.
Basso Stephen
Jungles Steven J
Wenkert Deborah
Novo Holdings A/S
Huertas Pedro
Sanofi
Makower Joshua
Powell Michael
Sofinnova Management X, L.P.
Sofinnova Venture Partners X, L.P.
Healy James
Katabi Maha
Alexion Pharmaceuticals Inc
Schlessinger Joseph
Rock Springs Capital Master Fund LP
Rock Springs Capital LLC
Rock Springs Capital Management LP
Shah Rajeev M.
Kolchinsky Peter
RA Capital Management LP
NEA 15 GP LLC
NEA Partners 15, L.P.
New Enterprise Associates 15, L.P.
Baskett Forest
Florence Anthony A. Jr.
Makhzoumi Mohamad
Sandell Scott D
Sonsini Peter W.
Braddock Demetrios
Form 13F Holdings
Firm Period DFND Voting Shares
Adage Capital Partners GP LLC [2023-03-31] SOLE 4,265,138.0 4,265,138.0
Sofinnova Investments Inc [2023-03-31] SOLE 3,655,308.0 3,655,308.0
Deep Track Capital LP [2023-03-31] SOLE 3,250,000.0 3,250,000.0
Rock Springs Capital Management LP [2023-03-31] SOLE 3,214,900.0 3,214,900.0
Pivotal Bioventure Partners Investment Advisor LLC [2023-03-31] DFND 0.0 3,213,586.0
NEA Management Company LLC [2023-03-31] DFND 2,437,689.0 2,437,689.0
Sphera Funds Management Ltd [2023-03-31] DFND 1,781,858.0 1,781,858.0
Millennium Management LLC [2023-03-31] SOLE 1,691,075.0 1,691,075.0
CHI Advisors LLC [2023-03-31] DFND 1,342,191.0 1,342,191.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,317,874.0
Citadel Advisors LLC [2023-03-31] DFND 822,923.0 822,923.0
Affinity Asset Advisors LLC [2023-03-31] SOLE 751,796.0 751,796.0
FMR LLC [2023-03-31] DFND 702,996.0 702,996.0
Samsara Biocapital LLC [2023-03-31] SOLE 504,407.0 504,407.0
BlackRock Inc. [2023-03-31] SOLE 448,213.0 451,193.0
Laurion Capital Management LP [2023-03-31] SOLE 271,800.0 271,800.0
Geode Capital Management LLC [2023-03-31] DFND 241,208.0 241,208.0
Bioimpact Capital LLC [2023-03-31] SOLE 233,728.0 233,728.0
Overbrook Management Corp [2023-03-31] SOLE 219,326.0 219,326.0
Marshall Wace LLP [2023-03-31] OTR 0.0 195,097.0
Renaissance Technologies LLC [2023-03-31] SOLE 186,100.0 186,100.0
Knott David M Jr [2023-03-31] DFND 160,000.0 160,000.0
UBS OConnor LLC [2023-03-31] DFND 147,654.0 147,654.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 125,000.0 125,000.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 117,400.0 117,400.0
State Street Corp [2023-03-31] DFND 98,055.0 98,055.0
Two Sigma Investments LP [2023-03-31] SOLE 65,500.0 65,500.0
Susquehanna International Group LLP [2023-03-31] DFND 0.0 54,000.0
Jane Street Group LLC [2023-03-31] DFND 53,525.0 53,525.0
Cubist Systematic Strategies, LLC [2023-03-31] DFND 0.0 50,712.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com